Microstructural diffusion changes are independent of macrostructural volume loss in moderate to severe Alzheimer's

Elisa Canu1, Donald G McLaren, Michele E Fitzgerald

  • 1The National Centre for Research and Care of Alzheimer's and Mental Diseases, Brescia, Italy.

Insights

Alzheimer's disease (AD) causes brain atrophy and microstructural changes. This study reveals that diffusion imaging provides unique insights into AD pathology beyond volumetric measurements, improving our understanding of the disease.

Area of Science:

  • Neuroimaging
  • Neurology
  • Medical Physics

Background:

  • Alzheimer's disease (AD) is characterized by cerebral macrostructural atrophy.
  • Microstructural diffusion changes are observed in AD, but their unique contribution is unclear.

Purpose of the Study:

  • To determine the independent contribution of macrostructural and microstructural imaging modalities in moderate to severe Alzheimer's disease.
  • To investigate if microstructural diffusion changes offer unique information beyond volumetric atrophy in AD.

Main Methods:

  • Multi-modal MRI study involving diffusion-weighted and T1-weighted scans in 17 AD patients and 13 controls.
  • Analysis using ANCOVA to assess independent contributions of macrostructural (volume) and microstructural (fractional anisotropy, mean diffusivity) measures.
  • Voxel-wise covariate analysis to identify diffusion changes independent of atrophy and vice-versa.

Main Results:

  • Diffusion differences were found in key AD regions (medial temporal, retrosplenial) even after controlling for volumetric loss.
  • Independent volumetric differences were identified in areas like the entorhinal cortex and cerebellum.
  • Microstructure measures provided unique information not captured by volumetric mapping alone.

Conclusions:

  • Microstructural diffusion imaging offers unique insights into Alzheimer's disease pathology, complementary to volumetric assessments.
  • This multi-modal approach enhances the understanding of the topographical distribution of pathological changes in AD.
  • Findings contribute to a more comprehensive imaging-based characterization of Alzheimer's disease progression.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...